News
Acne is one of the most common dermatologic diagnoses across age spans. It’s the number one condition for which Af…
Judith Hellman, MD
The U.S. Food and Drug Administration (FDA) approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the ove…
Suneva Medical closed $25 million financing to support continued growth opportunities, the company reports.
This fina…
Neal Bhatia, MD and Joel Schlessinger, MD sit down as the medical editors of Practical Dermatology® to discuss the futu…
Joel Schlessinger, MD, Neal Bhatia, MD, FAAD
Ninety-nine percent people would have more confidence if their acne and acne scars were gone, according to a new survey …
Actress, producer and model Kate Bosworth is the new face of Allergan plc’s ACZONE® (dapsone) Gel, 7.5%.
AC…
In this edition of Derm Insider, host Neal Bhatia, MD talks to James Q. Del Rosso, DO and Hilary Baldwin, MD about a rec…
Hilary Baldwin MD, James Q. Del Rosso, DO, Neal Bhatia, MD, FAAD
New research published online in JAMA Dermatology suggests that teledermatology improves access to care. Experts predict…
DermWire.com
Where is Dermatology Headed?
Interpreting the Data: Isotretinoin and Monthly Monitoring
DermWireTV: Telemedicine and Access, Inappropriate Antibioti…